Institut Gustave Roussy

Institut Gustave Roussy is a research organisation in Villejuif, France that has taken part in 90 EU-funded projects since 2008, receiving €51.4M in EU funding and leading 14 as coordinator.

EU funding received€51.4M
EU projects90
As coordinator14
Running now45
First EU project2008
Latest project2026
CountryFrance
EU registration (PIC)999454924
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Institut Gustave Roussy's own share of each project, not the project's full budget.

  • Horizon Europe€28.8M · 39 projects
  • FP7 (2007 to 2013)€12.0M · 25 projects
  • Horizon 2020€8.0M · 17 projects
  • EU4Health Programme (EU4H)€1.9M · 6 projects
  • Euratom Research and Training Programme (EURATOM)€646k · 1 project
  • Erasmus+ (ERASMUS+)€110k · 2 projects

Projects

90 EU-funded projects, newest first. Institut Gustave Roussy led 14 of them as coordinator. Each links to the official record.

  • Nano-BITECoordinator

    Multispecific theranostic nano-engager platform

    Horizon Europe · 2026–2028 · Project on CORDIS ↗

    €150ktheir share
  • ABIGAIL4DPartner

    Advancing Breast cancer Individualised Generative AI for Longitudinal Outcomes

    Horizon Europe · 2026–2031 · Project on CORDIS ↗

    €490ktheir share
  • CHICCoordinator

    Clonal hematopoiesis in cancer

    Horizon Europe · 2026–2031 · Project on CORDIS ↗

    €1.5Mtheir share
  • THEODORAPartner

    immunoTHErapies targeting neOgenes in paeDiatric and adOlescent saRcomAs

    Horizon Europe · 2026–2032 · Project on CORDIS ↗

    €159ktheir share
  • ENACT-65Partner

    ENabling ACTion on Integrated Nutritional and Exercise Care in Cancer – for Patients 65 and Beyond

    Horizon Europe · 2026–2031 · Project on CORDIS ↗

    €210ktheir share
  • PHOENIXPartner

    Phase I/II trial of an Oral ER-stress iNducer in relapsed/refractory neuroblastoma and paediatric solid tumours

    Horizon Europe · 2026–2032 · Project on CORDIS ↗

    €100ktheir share
  • NEOTREGPartner

    Early clinical development of first-in-class EGL-001 targeting Tregs in head and neck squamous cell carcinoma, supported by AI-based pathomics

    Horizon Europe · 2026–2028 · Project on CORDIS ↗

    €975ktheir share
  • COMPASSPartner

    Cardio-Oncology Multidisciplinary Patient ASsistance Solution

    Horizon Europe · 2026–2031 · Project on CORDIS ↗

    €467ktheir share
  • HER-CAREPartner

    Hereditary and Early onset breast cancer: Comprehensive personalized Assessment, early Risk Evaluation, and clinical management

    Horizon Europe · 2026–2029 · Project on CORDIS ↗

    €315ktheir share
  • JA PCMAssociated partner

    Joint Action Personalised Cancer Medicine

    EU4Health Programme (EU4H) · 2025–2029 · Project on the EU portal ↗

    €1.1Mtheir share
  • LAPINAssociated partner

    The EU-US Lung Cancer Working Group: Lung cancer screening And Prevention INternationally

    EU4Health Programme (EU4H) · 2025–2027 · Project on the EU portal ↗

  • TRANSCEND-XRPartner

    Co-creation and implementation of an intervention to improve the understanding of TesticulaR cANcer late effects and unmet Supportive CarENeeDs of AYA survivors using eXtended Reality.

    Horizon Europe · 2025–2030 · Project on CORDIS ↗

    €1.0Mtheir share
  • PREDI-LYNCHPartner

    Validated non-invasive liquid biopsy tests for cancer PREDIction in LYNCH Syndrome

    Horizon Europe · 2025–2031 · Project on CORDIS ↗

    €90ktheir share
  • T-RAFICPartner

    Training network for tracking and controlling therapeutic immune cells in cancer

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

    €283ktheir share
  • SCALPELPartner

    Specific Conjugation of Antibodies to Lipid Photo-peroxidised cancer tissues for their immunogenic ELimination

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

    €626ktheir share
  • OASISCoordinator

    OPTIMAL METHODS TO CHARACTERIZE ADC RESISTANCE IN SOLID TUMORS AND IDENTIFY CLINICALLY USEFUL BIOMARKERS

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

    €3.3Mtheir share
  • PATH-FOR-YOUNGPartner

    Personalized Adjuvant Treatment for HR+/HER2- breast cancer FOR YOUNG patients

    Horizon Europe · 2025–2031 · Project on CORDIS ↗

    €435ktheir share
  • VIDAAssociated partner

    VHIO International postDoctoral programme for translAtional research

    Horizon Europe · 2025–2030 · Project on CORDIS ↗

  • SERPAssociated partner

    Erasmus Mundus Joint Master's programme in Surface, Electro, Radiation, and Photo-chemistry

    Erasmus+ (ERASMUS+) · 2024–2030 · Project on the EU portal ↗

  • MADCAMCoordinator

    Microbiota-controlled trafficking of immunosuppressive intestinal T cells into cancer

    Horizon Europe · 2024–2029 · Project on CORDIS ↗

    €2.5Mtheir share
  • EUnetCCC JAAssociated partner

    The European Comprehensive Cancer Centre Network

    EU4Health Programme (EU4H) · 2024–2028 · Project on the EU portal ↗

    €401ktheir share
  • AltheaAssociated partner

    tAckLing menTal Health cancer patients and their families: digital solutions for bEtter cAre

    EU4Health Programme (EU4H) · 2024–2028 · Project on the EU portal ↗

    €92ktheir share
  • TREATLIVMETSPartner

    Treating Liver Metastasis

    Horizon Europe · 2024–2030 · Project on CORDIS ↗

    €2.9Mtheir share
  • EUCanScreenAssociated partner

    Implementation of cancer screening programmes.

    EU4Health Programme (EU4H) · 2024–2028 · Project on the EU portal ↗

    €210ktheir share
  • e-QuoLAssociated partner

    e-health tools to promote Equality in Quality of Life for childhood to young adulthood cancer patients, survivors and their families - a PanEuropean project supported by PanCare and Harmonic consortia

    Horizon Europe · 2024–2027 · Project on CORDIS ↗

  • MONALISAPartner

    A SIOPEN pragmatic clinical trial to MOnitor NeuroblastomA relapse with LIquid biopsy Sensitive Analysis

    Horizon Europe · 2024–2028 · Project on CORDIS ↗

    €85ktheir share
  • HIT-GLIOPartner

    Targeting tumour-host interactions in paediatric malignant gliomas to reinvigorate immunity and improve radio- and immunotherapy efficacy

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €1.8Mtheir share
  • RealCarePartner

    Real-time biomarker detection systems for rapid medical decision-making in cancer and cardiac diseases

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

    €1.5Mtheir share
  • ETICANCoordinator

    ECM and TFEB interplay: from building multidisciplinary devices to unravelling the missing link in cancer

    Horizon Europe · 2023–2025 · Project on CORDIS ↗

    €196ktheir share
  • FutureData4EUAssociated partner

    Training Future Big Data Experts for Europe

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

  • ERN PaedCan-Y7-Y10Partner

    European Reference Network on Paediatric Cancer

    EU4Health Programme (EU4H) · 2023–2027 · Project on the EU portal ↗

    €133ktheir share
  • AECC TalentAssociated partner

    FCAECC Fellowship programme for talented researchers in cancer

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

  • exTraAssociated partner

    Innovative Applications of Extracorporeal Photopheresis in Solid Organ Transplantation

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

  • TargetSWItchCoordinator

    Targeting SWI/SNF-related chromatin remodelling defects in solid tumours

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

    €1.5Mtheir share
  • CCI4EUPartner

    COMPREHENSIVE CANCER INFRASTRUCTURES 4 EUROPE

    Horizon Europe · 2023–2026 · Project on CORDIS ↗

    €372ktheir share
  • SALVOVARPartner

    A EUROPEAN MULTI-DISCIPLINARY CLINICAL PROJECT MEANT TO IMPROVE THE MANAGEMENT OF PATIENTS WITH POOR PROGNOSTIC OVARIAN CANCER AFTER NEOADJUVANT CHEMOTHERAPY: RESTORING HOPE, SALVAGING LIVES

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

    €144ktheir share
  • CARE1Coordinator

    First line randomized study platform to optimize treatment in patients with metastatic renal cell carcinoma

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

    €2.1Mtheir share
  • PragmaTILPartner

    Pragmatic approach to Adoptive Cell Therapy (ACT) using Tumor Infiltrating Lymphocytes (TIL) in selected solid tumors

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

    €219ktheir share
  • ThermoBreastPartner

    An innovative non-contact and harmless screening modality set to change the course of breast cancer detection and patient monitoring

    Horizon Europe · 2023–2026 · Project on CORDIS ↗

    €571ktheir share
  • EUonQoLPartner

    Quality of Life in Oncology: measuring what matters for cancer patients and survivors in Europe

    Horizon Europe · 2023–2026 · Project on CORDIS ↗

    €289ktheir share
Show 40 more projects
  • PREVALUNG EUCoordinator

    Biomarkers affecting the transition from cardiovascular disease to lung cancer: towards stratified interception.

    Horizon Europe · 2022–2027 · Project on CORDIS ↗

    €2.4Mtheir share
  • CGI-ClinicsPartner

    Data-driven cancer genome interpretation for personalised cancer treatment

    Horizon Europe · 2022–2027 · Project on CORDIS ↗

    €381ktheir share
  • STRONG-AYAPartner

    THE STRONG-AYA INITIATIVE: IMPROVING THE FUTURE OF YOUNG ADULTS WITH CANCER

    Horizon Europe · 2022–2027 · Project on CORDIS ↗

    €630ktheir share
  • SilkPlateletPartner

    Closing the European gap towards a large scale ex vivo platelet production built upon a silk-based scaffold bioreactor

    Horizon Europe · 2022–2025 · Project on CORDIS ↗

    €499ktheir share
  • CANPLASTAssociated partner

    Cancer cell plasticity on targeted therapy

    Horizon Europe · 2022–2027 · Project on CORDIS ↗

  • PIANOFORTEAssociated partner

    Partnership for european research in radiation protection and detection of ionising radiation : towards a safer use and improved protection of the environment and human health.

    Horizon Europe · 2022–2029 · Project on CORDIS ↗

    €646ktheir share
  • PIANOFORTEAssociated partner

    Partnership for european research in radiation protection and detection of ionising radiation : towards a safer use and improved protection of the environment and human health.

    Euratom Research and Training Programme (EURATOM) · 2022–2029 · Project on the EU portal ↗

    €646ktheir share
  • ALADDINPartner

    Multi-stakeholder Education Alliance to Accelerate Drug Development for Children and Adolescent with Cancer (ALADDIN)

    Erasmus+ (ERASMUS+) · 2022–2025 · Project on the EU portal ↗

    €110ktheir share
  • SPeR-ToNECoordinator

    Spermidine in hypertension: therapeutic potential and novel mechanisms

    Horizon 2020 · 2022–2025 · Project on CORDIS ↗

    €197ktheir share
  • IHMCSAPartner

    International Human Microbiome Coordination and Support Action

    Horizon 2020 · 2021–2024 · Project on CORDIS ↗

    €25ktheir share
  • CCE_DARTPartner

    Building Data Rich Clinical Trials

    Horizon 2020 · 2021–2025 · Project on CORDIS ↗

    €73ktheir share
  • TRELPartner

    Twinning in Research and Education to improve survival in Childhood Solid Tumours in Lithuania

    Horizon 2020 · 2021–2023 · Project on CORDIS ↗

    €47ktheir share
  • RadoNormPartner

    Towards effective radiation protection based on improved scientific evidence and social considerations - focus on radon and NORM

    Horizon 2020 · 2020–2025 · Project on CORDIS ↗

    €306ktheir share
  • 4-IN THE LUNG RUNPartner

    4-IN THE LUNG RUN: towards INdividually tailored INvitations, screening INtervals, and INtegrated co-morbidity reducing strategies in lung cancer screening

    Horizon 2020 · 2020–2025 · Project on CORDIS ↗

    €126ktheir share
  • NeutroCurePartner

    Development of “smart” amplifiers of reactive oxygen species specific to aberrant polymorphonuclear neutrophils for treatment of inflammatory and autoimmune diseases, cancer and myeloablation.

    Horizon 2020 · 2020–2025 · Project on CORDIS ↗

    €120ktheir share
  • HARMONICPartner

    Health effects of cArdiac fluoRoscopy and MOderN radIotherapy in paediatriCs

    Horizon 2020 · 2019–2024 · Project on CORDIS ↗

    €345ktheir share
  • IMMUcanPartner

    Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts

    Horizon 2020 · 2019–2026 · Project on CORDIS ↗

    €234ktheir share
  • ONCOBIOMECoordinator

    Gut OncoMicrobiome Signatures (GOMS) associated with cancer incidence, prognosis and prediction of treatment response.

    Horizon 2020 · 2019–2025 · Project on CORDIS ↗

    €2.9Mtheir share
  • MyPeBSPartner

    International Randomized Study Comparing personalized, Risk-Stratified to Standard Breast Cancer Screening In Women Aged 40-70

    Horizon 2020 · 2018–2027 · Project on CORDIS ↗

    €535ktheir share
  • CLINGLIOPartner

    A Clinical Phase IIB trial with 2OHOA in patients with newly-diagnosed malignant glioma.

    Horizon 2020 · 2017–2022 · Project on CORDIS ↗

    €117ktheir share
  • SilkFUSIONPartner

    Genetically engineered human pluripotent stem cells, functionalized silk-fibroin platforms and bio-inks: a novel solution for large-scale ex-vivo platelet production, transfusion and drug research

    Horizon 2020 · 2017–2022 · Project on CORDIS ↗

    €688ktheir share
  • ITCC-P4Partner

    ITCC Pediatric Preclinical POC Platform – Sofia ref.: 116064

    Horizon 2020 · 2017–2023 · Project on CORDIS ↗

    €501ktheir share
  • TKI resistanceCoordinator

    Resistance mechanisms to tyrosine kinase inhibitors in solid tumors

    Horizon 2020 · 2016–2021 · Project on CORDIS ↗

    €1.5Mtheir share
  • IMMUTRAINPartner

    Training Network for the Immunotherapy of Cancer

    Horizon 2020 · 2015–2019 · Project on CORDIS ↗

    €263ktheir share
  • ALKATRASPartner

    ALK Activation as a target of TRAanslational Science (ALKATRAS): Break free from cancer

    Horizon 2020 · 2015–2019 · Project on CORDIS ↗

  • CANCER-IDPartner

    Cancer treatment and monitoring through identification of circulating tumour cells and tumour related nucleic acids in blood

    FP7 (2007 to 2013) · 2015–2019 · Project on CORDIS ↗

    €320ktheir share
  • EECPartner

    EURO EWING Consortium – International Clinical Trials to Improve Survival from Ewing Sarcoma

    FP7 (2007 to 2013) · 2013–2019 · Project on CORDIS ↗

    €72ktheir share
  • MERITPartner

    Mutanome Engineered RNA Immuno-Therapy

    FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗

    €454ktheir share
  • WINTHERCoordinator

    WINTHERapeutics: development of a systems biology method to predict efficacy of cancer drugs to optimize individualized therapeutic decision and improve clinical outcome for cancer patients

    FP7 (2007 to 2013) · 2013–2015 · Project on CORDIS ↗

    €991ktheir share
  • CAReIOCAPartner

    Non-Invasive Optical Biopsy for Cancer Assessment using ultra high resolution Full-Field Optical Coherence Tomography

    FP7 (2007 to 2013) · 2012–2015 · Project on CORDIS ↗

    €429ktheir share
  • RAIDSPartner

    Rational molecular Assessments and Innovative Drug Selection

    FP7 (2007 to 2013) · 2012–2017 · Project on CORDIS ↗

    €546ktheir share
  • CTCTRAPPartner

    Circulating Tumor Cells TheRapeutic APheresis: a novel biotechnology enabling personalized therapy for all cancer patients

    FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗

    €386ktheir share
  • MELENDO2Coordinator

    Genetic epidemiological investigation into the association between endometriosis and cutaneous melanoma

    FP7 (2007 to 2013) · 2012–2015 · Project on CORDIS ↗

    €269ktheir share
  • BIOtracheaPartner

    Biomaterials for Tracheal Replacement in Age-related Cancer via a Humanly Engineered Airway

    FP7 (2007 to 2013) · 2012–2017 · Project on CORDIS ↗

    €80ktheir share
  • RESPONSIFYPartner

    Genome-based biomarkers leading to validated molecular diagnostic tests for response prediction in breast cancer

    FP7 (2007 to 2013) · 2012–2015 · Project on CORDIS ↗

    €427ktheir share
  • EUROSARCPartner

    European Clinical trials in Rare Sarcomas within an integrated translational trial network

    FP7 (2007 to 2013) · 2011–2018 · Project on CORDIS ↗

    €206ktheir share
  • COMBIOMPartner

    STRENGTHENING COOPERATION IN MOLECULAR BIOMEDICINE BETWEEN EU AND UKRAINE

    FP7 (2007 to 2013) · 2011–2015 · Project on CORDIS ↗

    €55ktheir share
  • CEREBRADPartner

    Cognitive and Cerebrovascular Effects Induced by Low Dose Ionising Radiation

    FP7 (2007 to 2013) · 2011–2015 · Project on CORDIS ↗

    €250ktheir share
  • PROCARDIOPartner

    Cardiovascular Risk from Exposure to Low-dose and Low-dose-rate Ionizing Radiation

    FP7 (2007 to 2013) · 2011–2015 · Project on CORDIS ↗

    €270ktheir share
  • ARTFORCEPartner

    Adaptive and innovative Radiation Treatment FOR improving Cancer patients treatment outcomE

    FP7 (2007 to 2013) · 2011–2017 · Project on CORDIS ↗

    €486ktheir share

Showing the 80 most recent of 90 projects.

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • DNA
  • DNA viruses
  • RNA
  • agriculture
  • alkaline earth metals
  • amorphous semiconductors
  • antibiotics
  • big data
  • bioeconomy
  • biomaterials
  • biophysics
  • breast cancer
  • cardiology
  • cardiovascular diseases

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime